This is not the most recent version of the article. View current version (7 APR 2016)

Intervention Review

You have free access to this content

Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis

  1. Larry C Lands1,*,
  2. Sanja Stanojevic2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 13 JUN 2013

Assessed as up-to-date: 23 MAY 2013

DOI: 10.1002/14651858.CD001505.pub3


How to Cite

Lands LC, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD001505. DOI: 10.1002/14651858.CD001505.pub3.

Author Information

  1. 1

    Montreal Children's Hospital, Department of Pediatrics, Montreal, Quebec, Canada

  2. 2

    The Hospital for Sick Children, Child Health Evaluative Sciences & Respiratory Medicine, Toronto, Ontario, Canada

*Larry C Lands, Department of Pediatrics, Montreal Children's Hospital, 2300 Tupper Street, Montreal, Quebec, H3H-1PA, Canada. larry.lands@muhc.mcgill.ca.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 13 JUN 2013

SEARCH

This is not the most recent version of the article. View current version (07 APR 2016)

[Analysis 1.1]
Analysis 1.1. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 1 Annual rate of change in % predicted FEV1.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 2 Annual rate of change in % predicted FEV1 (split by age).
[Analysis 1.3]
Analysis 1.3. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 3 Annual rate of change in % predicted FVC.
[Analysis 1.4]
Analysis 1.4. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 4 Annual rate of change in % predicted FVC (split by age).
[Analysis 1.5]
Analysis 1.5. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 5 Annual rate of change in % predicted FEF25-75%.
[Analysis 1.6]
Analysis 1.6. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 6 Annual rate of change in % predicted FEF25-75% (split by age).
[Analysis 1.7]
Analysis 1.7. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 7 Proportion with at least one respiratory hospitalisation.
[Analysis 1.8]
Analysis 1.8. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 8 Proportion with at least one hospital admission.
[Analysis 1.9]
Analysis 1.9. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 9 Number of deaths.
[Analysis 1.10]
Analysis 1.10. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 10 Annual rate of change in % ideal body weight.
[Analysis 1.11]
Analysis 1.11. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 11 Annual rate of change in % ideal body weight (split by age).
[Analysis 1.12]
Analysis 1.12. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 12 Chest X-ray score.
[Analysis 1.13]
Analysis 1.13. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 13 Chest X-ray score (split by age).
[Analysis 1.14]
Analysis 1.14. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 14 Increase in abdominal pain.
[Analysis 1.15]
Analysis 1.15. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 15 Decrease in abdominal pain.
[Analysis 1.16]
Analysis 1.16. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 16 Proportion with at least one gastrointestinal hospitalisation.
[Analysis 1.17]
Analysis 1.17. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 17 Stool frequency.
[Analysis 1.18]
Analysis 1.18. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 18 Occult blood.
[Analysis 1.19]
Analysis 1.19. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 19 Increase in epistaxis.
[Analysis 1.20]
Analysis 1.20. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 20 Decrease in epistaxis.
[Analysis 1.21]
Analysis 1.21. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 21 Increase in conjunctivitis.
[Analysis 1.22]
Analysis 1.22. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 22 Decrease in conjunctivitis.
[Analysis 1.23]
Analysis 1.23. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 23 Increase in nausea.
[Analysis 1.24]
Analysis 1.24. Comparison 1 Oral nonsteroidal anti-inflammatory drug versus placebo, Outcome 24 Increase in diarrhoea.